Dr. Ramachandran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
301 Seton Pkwy
Ste 104
Round Rock, TX 78665Phone+1 512-687-2300Fax+1 512-687-2376
Summary
- I am a dual trained Hematologist/Oncologist from USA and UK. I am a Royal College certified hematologist from England with FRCP and FRCPath, with additional training in hematology/Oncology from Brooklyn, New York.
I am also Board certified in Internal Medicine. My IM residency is from Case Western University, Cleveland and Hematology/Oncology Fellowship is from Brookdale University Hospital, Brooklyn, New York.
Education & Training
- University of Bristol Medical SchoolClass of 2009, Fellowship in Hematology, Royal College of Pathologists (London)
- One Brooklyn Health System/Brookdale University Hospital and Medical CenterFellowship, Hematology and Medical Oncology
- The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine
Certifications & Licensure
- TX State Medical License 2019 - 2026
- CO State Medical License 2023 - 2025
- KS State Medical License 2020 - 2023
- MO State Medical License 2019 - 2023
- NE State Medical License 2022 - 2022
- NY State Medical License 2017 - 2020
- OH State Medical License 2015 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Royal College of Hematology, EnglandFRCP ( Hematology) - 2011
- Royal College of Physicians, LondonFRCP-2009
Awards, Honors, & Recognition
- Institutional First Prize in Research Competition Brookdale University Hospitals and Medical Center, 2018
- Speciality First Prize in Hematology Brooklyn 4th Annual Research Day, 2018
Clinical Trials
- Myelofibrosis and Essential Thrombocythemia Observational Study (MOST) Start of enrollment: 2016 Dec 31
- KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment Start of enrollment: 2019 Jan 15
- A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib Start of enrollment: 2019 Mar 27
Publications & Presentations
PubMed
- 1 citationsPolycythemia Vera Presenting With Normal Hemoglobin and Hematocrit: A Rare Variant.Burak Erdinc, Preethi Ramachandran, Avezbakiyev Boris
Cureus. 2020-06-02 - 62 citationsAcute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.Umar Zahid, Preethi Ramachandran, Samuel Spitalewitz, Lutfi Alasadi, Abhishek Chakraborti
American Journal of Nephrology. 2020-10-02 - 67 citationsGastrointestinal Symptoms and Outcomes in Hospitalized Coronavirus Disease 2019 Patients.Preethi Ramachandran, Ifeanyichkwu Onukogu, Snigdha Ghanta, Mahesh Gajendran, Abhilash Perisetti
Digestive Diseases. 2020-06-29
Journal Articles
- Autoimmune Heparin-Induced Thrombocytopenia: Treatment Obstacles and Challenging Length of StayRamachandran P, Farag F, Morcus R, Gotlieb V, Am J Case Rep, 1/9/2019
- A Rare Case of Advanced Urethral Diverticular Adenocarcinoma and a Review of Treatment ModalitiesOluyadi F, Ramachandran P, Gotlieb V, J Investig Med High Impact Case Rep, 1/1/2019
- An Unusual Presentation of Merkel Cell Carcinoma in a HIV Patient: A Case Report and Literature ReviewRamachandran P, Erdinc B, Gotlieb V, J Investig Med High Impact Case Rep, 1/1/2019
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- 2 Week Wait cancer target referrals in HematologyRamachandran P, Whiteway A, British Society of Hematology Conference, England
- A Rare Case of Non-Umbilical Cutaneous Metastasis as a First Presentation of a Very Aggressive Pancreatic CancerP. Ramachandran MD, G Joseph MD, American College of Gastroenterology Conference, Philadelphia, USA
- Primary Gastrointestinal De Novo CD5+ CD23+ Diffuse Large B-Cell Lymphoma (DLBCL): A Different Treatment ApproachP. Ramachandran MD, R. Morcus, H. Taha, American College of Gastroenterology Conference, Philadelphia, USA
- Join now to see all
Committees
- Research Comittee Administrator, Brookdale Research Comittee 2018 - 2019
Professional Memberships
- Member
- Member
- Member
- Royal College of Physicians, LondonFellow
- Royal College of Pathologists, LondonFellow
- Indian Medical AssociationMember
- Tamil Nadu Medical AssociationMember
- ECFMGMember
- Member
- Federation of State Medical Boards (FSMB)Member
Other Languages
- Kannada, Tamil, Telugu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: